Radiation Oncology/Therapy: Page 202

PET/MRI offers diagnostic accuracy for lymph node staging
By Wayne Forrest
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA12-04 | Room S504CDPET/MRI provides sufficient diagnostic accuracy for lymph node metastases detection, while diffusion-weighted MRI images are inaccurate for staging in head and neck cancer patients, according to researchers from the University of Düsseldorf.
November 7, 2012
Antidepressant rinse reduces pain for cancer patients after RT
By Cynthia E. Keen
When used as a rinse, doxepin, a tricyclic antidepressant, reduces oral mucositis pain in patients who receive radiation therapy (RT) for head and neck cancer, according to research from the Mayo Clinic presented at the recent American Society for Radiation Oncology annual meeting.
November 6, 2012
Elastography offers alternative for evaluating soft-tissue lesions
By Kate Madden Yee
Tuesday, November 27 | 5:00 p.m.-5:30 p.m. | LL-MKS-TU4C | Lakeside Learning CenterUltrasound elastography could be a useful tool for evaluating superficial soft-tissue lesions, according to this Tuesday poster presentation from Italian researchers.
November 6, 2012
CEUS comparable to MDCT for managing colorectal cancer patients
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-GIS-SU2A | Lakeside Learning CenterContrast-enhanced ultrasound (CEUS) is comparable to MDCT in assessing patients undergoing antiangiogenic drug-based neoadjuvant therapy for colorectal cancer liver metastasis, according researchers from Italy.
November 6, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 6, 2012
Contrast-enhanced US tracks cancer response to drug therapy
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA21-04 | Room S405ABVolumetric contrast-enhanced ultrasound can track positive early cancer response to systemic drug therapy, according to a presentation to be given by researchers from the University of Alabama on Sunday morning.
November 6, 2012
iCAD supports new IORT payments
By AuntMinnie.com staff writers
Computer-aided detection (CAD) firm iCAD said that it is pleased that the U.S. Centers for Medicare and Medicaid Services issued an improved payment policy for intraoperative radiation therapy (IORT) in 2013.
November 5, 2012
Drug aids sexual function of prostate cancer patients after RT
By Cynthia E. Keen
Sildenafil citrate improves overall sexual function of prostate cancer patients who received radiation therapy (RT), according to trial results presented by researchers from Memorial Sloan-Kettering Cancer Center at the American Society for Radiation Oncology annual meeting.
November 5, 2012
Radiation concerns broaden beyond CT in ECRI 2013 hazards list
By Eric Barnes
Medical imaging radiation once again made the list of the ECRI Institute's top 10 rankings of technology hazards for 2013. But this year, the nonprofit group expanded the category from just CT to include a broader range of imaging-related radiation hazards.
November 5, 2012
Quantification replaces attenuation measurement for characterizing renal masses
By Eric Barnes
Friday, November 30 | 11:30 a.m.-11:40 a.m. | SST07-07 | Room E351Iodine quantification at dual-energy CT is a new diagnostic technique that can reduce the cost of additional tests in the characterization of renal masses, researchers from the University of Messina in Italy have found.
November 5, 2012
Single-phase CT of the liver sufficient for melanoma surveillance
By Eric Barnes
Friday, November 30 | 11:10 a.m.-11:20 a.m. | SST05-05 | Room E353CSingle portal-venous phase CT is adequate for hepatic metastatic disease surveillance in patients with metastatic cutaneous melanoma, concluded researchers from Utah, who found that arterial-phase CT didn't provide much additional information.
November 5, 2012
Study pinpoints optimal ASIR blend for stomach cancer
By Eric Barnes
Wednesday, November 28 | 3:40 p.m.-3:50 p.m. | SSM08-05 | Room E353BWhat's the best blend of adaptive statistical iterative reconstruction (ASIR) for evaluating gastric cancers for postoperative follow-up? Researchers from South Korea wanted to minimize radiation dose but avoid missing a recurrence, so they systematically analyzed the results of different blends.
November 5, 2012
Previous Page
Page 202 of 467
Next Page